Search

everythinglearnresearchcommunity

for

Search:↓

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Procyanidins from grape seeds reduce nerve pain by blocking specific proteins and inflammation.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Polydeoxyribonucleotide (PDRN) may help lighten skin and treat hyperpigmentation.

Wnt7a protein is crucial for development and tissue maintenance and plays varying roles in diseases and potential treatments.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Damaged hair follicles make mice more prone to skin inflammation and skin cancer after UV exposure.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Melanocytes are important for skin and hair color and protect the skin from UV damage.

The cornified envelope is crucial for skin's barrier function and involves key proteins and genetic factors.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Cell death shapes skin stem cell environments, affecting inflammation, repair, and cancer.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

The document concludes that scalp health is influenced by complex factors affecting sebaceous glands, including hormones, aging, and various substances.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Air pollution worsens skin diseases and aging by causing inflammation and oxidative stress.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Special fiber materials boost the healing properties of certain stem cells.

Periodontal ligament stem cells show promise for regrowing tissues but require more research for safe, effective use.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.